These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11785689)

  • 41. In vitro iontophoretic release of lithium chloride and lidocaine hydrochloride from polymer electrolytes.
    Sahota TS; Latham RJ; Linford RG; Taylor PM
    Drug Dev Ind Pharm; 2000 Oct; 26(10):1039-44. PubMed ID: 11028218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transungual iontophoretic transport of polar neutral and positively charged model permeants: effects of electrophoresis and electroosmosis.
    Hao J; Li SK
    J Pharm Sci; 2008 Feb; 97(2):893-905. PubMed ID: 17683062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of vasoactive drugs on transdermal lidocaine iontophoresis.
    Riviere JE; Sage B; Williams PL
    J Pharm Sci; 1991 Jul; 80(7):615-20. PubMed ID: 1941556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.
    Sekkat N; Kalia YN; Guy RH
    Pharm Res; 2004 Aug; 21(8):1390-7. PubMed ID: 15359573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-invasive targeted iontophoretic delivery of cetuximab to skin.
    Lapteva M; Sallam MA; Goyon A; Guillarme D; Veuthey JL; Kalia YN
    Expert Opin Drug Deliv; 2020 Apr; 17(4):589-602. PubMed ID: 32067504
    [No Abstract]   [Full Text] [Related]  

  • 47. Iontophoresis on Porcine and Human Gingiva.
    Wanasathop A; Nimmansophon P; Murawsky M; Krishnan DG; Li SK
    Pharm Res; 2023 Aug; 40(8):1977-1987. PubMed ID: 37258949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of the permselective properties of rabbit skin during transdermal iontophoresis.
    Nicoli S; Cappellazzi M; Colombo P; Santi P
    J Pharm Sci; 2003 Jul; 92(7):1482-8. PubMed ID: 12820152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iontophoretic transport across a multiple membrane system.
    Molokhia SA; Zhang Y; Higuchi WI; Li SK
    J Pharm Sci; 2008 Jan; 97(1):490-505. PubMed ID: 17990310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of lipids on the mannitol flux during transdermal iontophoresis in vitro.
    Kirjavainen M; Urtti A; Mönkkönen J; Hirvonen J
    Eur J Pharm Sci; 2000 Apr; 10(2):97-102. PubMed ID: 10727874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transport behavior of hairless mouse skin during constant current DC iontophoresis, part 2: iontophoresis of nonionic molecules with cotransport of polystyrene sulfonate oligomers.
    Liddell MR; Li SK; Higuchi WI
    J Pharm Sci; 2011 Jul; 100(7):2816-25. PubMed ID: 21455977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computational and experimental model of transdermal iontophorethic drug delivery system.
    Filipovic N; Saveljic I; Rac V; Graells BO; Bijelic G
    Int J Pharm; 2017 Nov; 533(2):383-388. PubMed ID: 28576549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transdermal iontophoresis.
    Batheja P; Thakur R; Michniak B
    Expert Opin Drug Deliv; 2006 Jan; 3(1):127-38. PubMed ID: 16370945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of pH on Iontophoretic Transport of Pramipexole Dihydrochloride across Human Epidermal Membrane.
    Saepang K; Li SK; Chantasart D
    Pharm Res; 2021 Apr; 38(4):657-668. PubMed ID: 33826056
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches.
    Hu L; Silva SM; Damaj BB; Martin R; Michniak-Kohn BB
    Int J Pharm; 2011 Dec; 421(1):53-62. PubMed ID: 21963468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate.
    Telò I; Tratta E; Guasconi B; Nicoli S; Pescina S; Govoni P; Santi P; Padula C
    Int J Pharm; 2016 Jun; 506(1-2):420-8. PubMed ID: 27113869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration.
    Sahraoui PF; Vadas O; Kalia YN
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iontophoresis: electrorepulsion and electroosmosis.
    Guy RH; Kalia YN; Delgado-Charro MB; Merino V; López A; Marro D
    J Control Release; 2000 Feb; 64(1-3):129-32. PubMed ID: 10640651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.